作者：
Damiano,Rondelli [1]
;
Judith D,Goldberg [2]
;
Luis,Isola [3]
;
Leah S,Price [2]
;
Tsiporah B,Shore [4]
;
Michael,Boyer [5]
;
Andrea,Bacigalupo [6]
;
Alessandro,Rambaldi [7]
;
Marco,Scarano [8]
;
Rebecca B,Klisovic [9]
;
Vikas,Gupta [10]
;
Bjorn,Andreasson [11]
;
John,Mascarenhas [3]
;
Meir,Wetzler [12]
;
Alessandro M,Vannucchi [13]
;
Josef T,Prchal [14]
;
Vesna,Najfeld [3]
;
Attilio,Orazi [4]
;
Rona S,Weinberg [15]
;
Crystal,Miller [3]
;
Giovanni,Barosi [16]
;
Lewis R,Silverman [3]
;
Giuseppe,Prosperini [8]
;
Roberto,Marchioli [8]
;
Ronald,Hoffman [3]
作者单位：
University of Illinois Hospital & Health Sciences System and University of Illinois Cancer Center, Chicago, IL; Myeloproliferative Disorders Research Consortium, Mount Sinai School of Medicine, New York, NY;
[1]
Myeloproliferative Disorders Research Consortium, Mount Sinai School of Medicine, New York, NY; New York University School of Medicine, New York, NY;
[2]
Myeloproliferative Disorders Research Consortium, Mount Sinai School of Medicine, New York, NY; Mount Sinai Medical Center, New York, NY;
[3]
Myeloproliferative Disorders Research Consortium, Mount Sinai School of Medicine, New York, NY; Weill Cornell Medical College, New York, NY;
[4]
University of Utah School of Medicine, Salt Lake City, UT;
[5]
Myeloproliferative Disorders Research Consortium, Mount Sinai School of Medicine, New York, NY; Ospedale San Martino, Genoa, Italy;
[6]
Myeloproliferative Disorders Research Consortium, Mount Sinai School of Medicine, New York, NY; Azienda Ospedaliera Papa Giovanni XXIII, Bergamo, Italy;
[7]
Myeloproliferative Disorders Research Consortium, Mount Sinai School of Medicine, New York, NY; Foundation Mario Negri Sud, S. Maria Imbaro, Italy;
[8]
Myeloproliferative Disorders Research Consortium, Mount Sinai School of Medicine, New York, NY; The Ohio State University Comprehensive Cancer Center, Columbus, OH;
[9]
Myeloproliferative Disorders Research Consortium, Mount Sinai School of Medicine, New York, NY; Princess Margaret Hospital Cancer Center, Toronto, ON, Canada;
[10]
Myeloproliferative Disorders Research Consortium, Mount Sinai School of Medicine, New York, NY; Nephro-Urology Hospital Organization, Uddevalla, Sweden;
[11]
Myeloproliferative Disorders Research Consortium, Mount Sinai School of Medicine, New York, NY; Roswell Park Cancer Institute, Buffalo, NY;
[12]
Myeloproliferative Disorders Research Consortium, Mount Sinai School of Medicine, New York, NY; University of Florence, Florence, Italy;
[13]
Myeloproliferative Disorders Research Consortium, Mount Sinai School of Medicine, New York, NY; University of Utah School of Medicine, Salt Lake City, UT;
[14]
Myeloproliferative Disorders Research Consortium, Mount Sinai School of Medicine, New York, NY; New York Blood Center, New York, NY; and.
[15]
Myeloproliferative Disorders Research Consortium, Mount Sinai School of Medicine, New York, NY; Istituto Di Ricovero e Cura a Carattere Scientifico Policlinico S. Matteo Foundation, Pavia, Italy.
[16]
DOI
10.1182/blood-2014-04-572545
PMID
24963042
发布时间
2022-03-11
换一批
换一批
